zanubrutinib,zandelisib
mei,kyowa kirin,beigene
['mantle,(-dismantle)', 'zandelisib', 'follicular', 'zanubrutinib', 'lymphoma']
#ash22 | la nouvelle orleans ballroom c | sat 9:30am cst
safety and efficacy of the pi3k inhibitor zandelisib in combination with the btk inhibitor zanubrutinib in patients with relapsed/refractory (r/r) follicular lymphoma (fl) or mantle cell lymphoma (mcl)
jacob soumerai, md 
The official Twitter account for Mass General Cancer Center, a member of Mass General Brigham.